Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Vamsi Madgula"'
Publikováno v:
Materials Today Bio, Vol 27, Iss , Pp 101143- (2024)
Recent FDA modernization act 2.0 has led to increasing industrial R&D investment in advanced in vitro 3D models such as organoids, spheroids, organ-on-chips, 3D bioprinting, and in silico approaches. Liver-related advanced in vitro models remain the
Externí odkaz:
https://doaj.org/article/a0ff8d62dfba48a19f8146aed4b4801a
Autor:
Veeravalli, Vijayabhaskar, Cheruvu, Hanumanth Srikanth, Srivastava, Pratima, Vamsi Madgula, Lakshmi Mohan
Publikováno v:
In Journal of Pharmaceutical Analysis December 2020 10(6):522-531
Autor:
Vijayabhaskar Veeravalli, Hanumanth Srikanth Cheruvu, Pratima Srivastava, Lakshmi Mohan Vamsi Madgula
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 10, Iss 6, Pp 522-531 (2020)
Formulation/pharmaceutical excipients play a major role in formulating drug candidates, with the objectives of ease of administration, targeted delivery and complete availability. Many excipients used in pharmaceutical formulations are orphanized in
Externí odkaz:
https://doaj.org/article/f0c2518b6c714b90917195fe765b2980
Autor:
Anna Kerins, Marta Koszyczarek, Caroline Smith, Phil Butler, Rob Riley, Vamsi Madgula, Nilkanth Naik, Matthew R. Redinbo, Ian D. Wilson
Publikováno v:
Xenobiotica. 52:904-915
Autor:
Anna, Kerins, Marta, Koszyczarek, Caroline, Smith, Phil, Butler, Rob, Riley, Vamsi, Madgula, Nilkanth, Naik, Matthew R, Redinbo, Ian D, Wilson
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 52(8)
Autor:
Lakshmi Mohan Vamsi Madgula, Hanumanth Srikanth Cheruvu, Pratima Srivastava, Vijayabhaskar Veeravalli
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 10, Iss 6, Pp 522-531 (2020)
Journal of Pharmaceutical Analysis
Journal of Pharmaceutical Analysis
Formulation/pharmaceutical excipients play a major role in formulating drug candidates, with the objectives of ease of administration, targeted delivery and complete availability. Many excipients used in pharmaceutical formulations are orphanized in
Autor:
Jennifer A. Thomas, R. Jayachandra Babu, Lakshmi Mohan Vamsi Madgula, Vijayabhaskar Veeravalli, Ranjeet Prasad Dash, Nuggehally R. Srinivas
Publikováno v:
Drug Safety. 43:711-725
The introduction of novel, small-molecule Janus kinase inhibitors namely tofacitinib, baricitinib and upadacitinib has provided an alternative treatment option for patients with rheumatoid arthritis outside of traditional drugs and expensive biologic
Autor:
Ashwinkumar V. Meru, Siddhartha De, Debnath Bhuniya, Nadim S. Shaikh, Kasim A. Mookhtiar, Kaushal Joshi, Rashmi Barbhaiya, Vamsi Madgula, Sandeep Bhosale, Amol A. Raje, Rajendra K. Kharul, Dhananjay Joshi, Amol Magdum, Fouzia Begum, Sonalee Athavankar, Hajare Atul Kashinath, Sandip Balwe
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 29:238-243
Conceptual design and modification of urea moiety in chemotype PF-3845/04457845, the bench marking irreversible inhibitor of fatty acid amide hydrolase (FAAH), led to discovery of a novel nicotinamide-based lead 12a having reversible mechanism of act
Autor:
Kasim A. Mookhtiar, Anita Chugh, Rahul D. Kaduskar, Siddhartha De, Dhananjay N. Umrani, Debnath Bhuniya, Keshav Naik, Santosh Kurhade, Prasad Shitole, Balasaheb Kobal, Pratima Patil, Amol A. Raje, Sandhya Chaturvedi Joshi, Vamsi Madgula, Vaibhav Jain, Satyanarayana Reddy, Vyavahare Vinod, Suhas Tambe, Venkata P. Palle, Jayasagar Gundu, Ganesh Bhat, Bhavesh Dave, Anil M. Deshpande, Sachin Kandalkar, Sujay Basu
Publikováno v:
European Journal of Medicinal Chemistry. 133:268-286
Glucokinase activators (GKAs) are among the emerging drug candidates for the treatment of type 2 diabetes (T2D). Despite effective blood glucose lowering in clinical trials, many pan-GKAs "acting both in pancreas and liver" have been discontinued fro
Autor:
Salunkhe Videsh, Madhu bala, Avinash Dhanave, Tanaji Mengawade, Vamsi Madgula, Mahesh Thakkar, Keshav Naik, Bheemashankar Kulkarni, Rahul D. Kaduskar, Dhananjay N. Umrani, Santosh Kurhade, Sachin Joshi, Amit Bhalerao, Sreekanth R. Rouduri, Vishal V Pathade, Rajkanth Petla, Swagatam Ray, Narayanan Hariharan, Kasim A. Mookhtiar, Satheesh Veerappa Avaragolla, Debnath Bhuniya, Jagadeesh Mavinahalli, Ashwini Tambe, Vaibhav Jain, Siddhartha De, Amol A. Raje, Ahmed Nadeem
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 27:1867-1873
In a pursuit to identify reversible and selective BTK inhibitors, two series based on 7H-pyrrolo[2,3-d]pyrimidine and 1H-pyrrolo[2,3-b]pyridine as the hinge binding core, have been identified. Structure activity relationship (SAR) exploration led to